Reimagining our Canadian Potential:  Working Together through Partnerships and Collaborations

October 23-24, 2023

MaRS Discovery District (Toronto) 101 College Street
Registration & Breakfast – Concourse Level Auditorium 7:00am
opening remarks at 8:30am

 Program

Recordings

• Day 1 
• Day 2

Slides (click on the titles)

October 23, 2023

From Guidance to real-world application: How can we continue to better use RWD in HTA decision-making?

Drug shortages

Prioritizing eye health for Canadians and system readiness

How value-based healthcare can be applied to improve evaluation and funding decisions in rare diseases and cancer, drawing on global examples and emerging best practices in Canada

Supporting innovative therapeutics for dementia treatment and beyond

Oral Presentations of top-ranked research abstracts

October 24, 2023

Early Morning Workshop: Propensity Scores – From lingo to applications in real world evidence

Rare Disease Strategy – Evolution, Needs and Future Steps

Exploring diverse approaches to health technology assessment and reimbursement for cancer therapies: Can new Canadian collaborations help enable timely access?

Public payer best practices for providing timely patient access to cancer therapies

 Abstract Booklet

Student Awards:
Dr. E. Keith Borden Award for Students

• Best Oral Presentation – Naomi Chouinard, “Comparing approaches to determine the costs of treating burn victims in Quebec”
• Best Poster Presentation – Lauren Tailor, “ASA prophylaxis for preeclampsia prevention: validation within a large administrative dataset“

Code of Conduct:
all attendees at the conference will be required to adhere to the CAPT Code of Conduct

 

Special thank you to our 2023 PARTNERS